12 Stocks with Heavy Insider Buying in 2025

2. Oscar Health, Inc. (NYSE:OSCR)

Number of Hedge Fund Holders: 43

Oscar Health, Inc. (NYSE:OSCR) is a leading healthcare technology company that operates primarily in the individual health insurance market through the Affordable Care Act (ACA) exchanges. The company offers health plans to individuals, families, and employees, with a strong focus on leveraging its full stack technology platform to provide superior member experience. OSCR’s strategic priorities include running a sustainable and scalable operation, continually investing in member experience, harnessing technology to power others in the healthcare system, and developing innovative offerings to expand the individual market.

Oscar Health, Inc. (NYSE:OSCR) reported its strongest financial performance in history for 2024, achieving total company adjusted EBITDA profitability of $199 million, representing a $245 million YoY improvement. The company achieved net income profitability of $25 million, marking a $296 million increase over the prior year. Total revenue grew by 57% YoY to $9.2 billion, while maintaining a stable medical loss ratio of 81.7%. The company demonstrated improved operational efficiency with its SG&A ratio improving by more than 500 basis points YoY to 19.1%. OSCR’s membership growth outpaced the market by nearly 3x at 37%, serving 1.8 million members as of February 2025.

The company’s strong performance was driven by competitively priced products, technology implementation, and superior member experience across its 18-state footprint. Looking ahead to 2025, Oscar Health, Inc. (NYSE:OSCR) expects total revenues to be in the range of $11.2 billion to $11.3 billion, with earnings from operations projected between $225 million to $275 million. The company remains committed to delivering at least 20% revenue CAGR and a 5% operating margin by 2027. OSCR’s capital position remains strong with $4 billion in cash and investments, including $190 million at the parent level and approximately $1.2 billion of capital and surplus in its insurance subsidiaries. Given the aforementioned developments, it is of no surprise that OSCR has experienced heavy insider buying in the last six months.